{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:32:30Z","timestamp":1762324350542,"version":"3.37.3"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The principal outcome was to identify which hypnotics substances, medicated (benzodiazepines, antihistamine, antidepressant\u2026) or not medicated (herbal medicine, homeopathy, melatonin\u2026), were consumed by community pharmacy patients who reported taking something for sleep disorder, and which factors can influence the consumption of medicated substance rather than nonmedicated substance. Data were collected via a network of 73 partner pharmacies around Nantes, France. Patients who reported taking a substance to sleep completed a questionnaire that collected data relative to the different substances consumed by that person for sleep, and the desired effect. Substances were classified in Hypnotic Drug Substances and nonmedicated hypnotic substances. A logistical regression was done in order to highlight the factors associated with the consumption of Hypnotic Drug Substance rather than nonmedicated hypnotic substances. Six hundred and forty\u2010seven patients were included, with an average age of 58 years and 74% female. The principal strategy employed to combat sleep disorder was the consumption of Hypnotic Drug Substance (54%), followed by herbal medicine (32%) and homeopathy (19%). The factors positively associated with the consumption of a Hypnotic Drug Substance are age, living alone, being out of work, or in the process of looking for a job and being a parent. In our survey, the use of Hypnotic Drug Substance to help patients with sleep is far from systematic. On the other hand, among patients who consume HDS, misuse is still significant, particularly in terms of the duration of consumption.<\/jats:p>","DOI":"10.1111\/fcp.12420","type":"journal-article","created":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T08:07:27Z","timestamp":1538813247000},"page":"216-222","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medicated or not medicated hypnotic substance use: strategies in sleep disorders among patients of community pharmacy"],"prefix":"10.1111","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-7008","authenticated-orcid":false,"given":"Delphine","family":"Lauzeille","sequence":"first","affiliation":[{"name":"Pharmacology department Centre d'Evaluation et d'Information sur la Pharmacod\u00e9pendance \u2010 Addictovigilance (CEIP\u2010A), Institut de Biologie 9 quai Moncousu 44093 Nantes cedex 01 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryl\u00e8ne","family":"Guerlais","sequence":"additional","affiliation":[{"name":"Pharmacology department Centre d'Evaluation et d'Information sur la Pharmacod\u00e9pendance \u2010 Addictovigilance (CEIP\u2010A), Institut de Biologie 9 quai Moncousu 44093 Nantes cedex 01 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Sallenave\u2010Namont","sequence":"additional","affiliation":[{"name":"Pharmacy Faculty UFR Sciences Pharmaceutiques et Biologiques 9 rue Bias BP 61112 44035 Nantes cedex 1 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Etcheverrigaray","sequence":"additional","affiliation":[{"name":"Pharmacology department Centre d'Evaluation et d'Information sur la Pharmacod\u00e9pendance \u2010 Addictovigilance (CEIP\u2010A), Institut de Biologie 9 quai Moncousu 44093 Nantes cedex 01 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Broccato","sequence":"additional","affiliation":[{"name":"Pharmacology department Centre d'Evaluation et d'Information sur la Pharmacod\u00e9pendance \u2010 Addictovigilance (CEIP\u2010A), Institut de Biologie 9 quai Moncousu 44093 Nantes cedex 01 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quentin","family":"Poisblaud","sequence":"additional","affiliation":[{"name":"Pharmacology department Centre d'Evaluation et d'Information sur la Pharmacod\u00e9pendance \u2010 Addictovigilance (CEIP\u2010A), Institut de Biologie 9 quai Moncousu 44093 Nantes cedex 01 France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Jolliet","sequence":"additional","affiliation":[{"name":"Pharmacology department Centre d'Evaluation et d'Information sur la Pharmacod\u00e9pendance \u2010 Addictovigilance (CEIP\u2010A), Institut de Biologie 9 quai Moncousu 44093 Nantes cedex 01 France"},{"name":"UMR INSERM 1246 \u2010 SPHERE, \u201cMethodS in Patients\u2010centered outcomes and HEalth ResEarch\u201d Institut de recherche en Sant\u00e9 2, 22 boulevard Benoni\u2010Goullin 44200 Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Victorri\u2010Vigneau","sequence":"additional","affiliation":[{"name":"Pharmacology department Centre d'Evaluation et d'Information sur la Pharmacod\u00e9pendance \u2010 Addictovigilance (CEIP\u2010A), Institut de Biologie 9 quai Moncousu 44093 Nantes cedex 01 France"},{"name":"UMR INSERM 1246 \u2010 SPHERE, \u201cMethodS in Patients\u2010centered outcomes and HEalth ResEarch\u201d Institut de recherche en Sant\u00e9 2, 22 boulevard Benoni\u2010Goullin 44200 Nantes France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17480-1"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.193"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X253771"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2013.02.011"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2175"},{"key":"e_1_2_7_7_1","doi-asserted-by":"crossref","unstructured":"CulpepperL. WingertzahnM.A.Over\u2010the\u2010counter agents for the treatment of occasional disturbed sleep or transient insomnia: a systematic review of efficacy and safety. Prim care companion CNS disord [Internet]. (2015); Available from:http:\/\/www.psychiatrist.com\/PCC\/article\/Pages\/2015\/v17n06\/15r01798.aspx","DOI":"10.4088\/PCC.15r01798"},{"key":"e_1_2_7_8_1","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9. Etat des lieux de la consommation des benzodiaz\u00e9pines en France. (2017)."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1053\/smrv.2002.0186"},{"key":"e_1_2_7_10_1","first-page":"502","article-title":"Insomnie, fatigue et somnolence\u202f: pr\u00e9valence et \u00e9tat de sant\u00e9 associ\u00e9, d\u00e9clar\u00e9s par les plus de 16 ans en France m\u00e9tropolitaine. Donn\u00e9es ESPS 2008","volume":"44","author":"Gourier\u2010Frery C.","year":"2012","journal-title":"BEH"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2011.05.005"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674371105600905"},{"key":"e_1_2_7_13_1","unstructured":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9. Etat des lieux de la consommation des benzodiaz\u00e9pines en France. (2013)."},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826081003777568"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2014.980952"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2005.08.008"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1087-0792(02)80001-6"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2007.10.016"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp12X625157"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2015.07.024"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-015-0166-4"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-011-9482-5"},{"key":"e_1_2_7_23_1","first-page":"CD007768","article-title":"Consumer\u2010oriented interventions for evidence\u2010based prescribing and medicine use: an overview of Cochrane reviews","volume":"5","author":"Ryan R.","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12328"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmw107"},{"key":"e_1_2_7_26_1","doi-asserted-by":"crossref","first-page":"e0145817","DOI":"10.1371\/journal.pone.0145817","article-title":"Patient preferences and shared decision making in the treatment of substance use disorders: a systematic review of the literature","volume":"5","author":"Friedrichs A.","year":"2016","journal-title":"PLoS ONE"},{"key":"e_1_2_7_27_1","unstructured":"Minist\u00e8re des affaires sociales et de la sant\u00e9.Arr\u00eat\u00e9 du 7 janvier 2017 portant application d'une partie de la r\u00e9glementation des stup\u00e9fiants aux m\u00e9dicaments \u00e0 base de zolpidem administr\u00e9s par voie orale [Internet]. Jan 10 2017. Available from:https:\/\/www.legifrance.gouv.fr\/jo_pdf.do?id=JORFTEXT000033843028"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ffcp.12420","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.12420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T16:32:26Z","timestamp":1694449946000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.12420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1111\/fcp.12420"],"URL":"https:\/\/doi.org\/10.1111\/fcp.12420","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"type":"print","value":"0767-3981"},{"type":"electronic","value":"1472-8206"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"assertion":[{"value":"2018-02-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}